Investigating the effect of Icaritin on hepatocellular carcinoma based on network pharmacology

Hepatocellular carcinoma is one of the cancers that kill people in the global population. Icaritin, a small molecule drug approved by NMPA, has demonstrated potential anti-HCC effects. However, its underlying molecular mechanisms remain unclear. We employed a multi-omics approach in this study, incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Zhong, Zhang, Fan, Xu, Shaohua, Chen, Minyong, Wang, Mingzuo, Wang, Ming, Ke, Fayong, Chen, Zhaoshuo, Zhang, Mingji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265681/
https://www.ncbi.nlm.nih.gov/pubmed/37324495
http://dx.doi.org/10.3389/fphar.2023.1208495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265681/
https://www.ncbi.nlm.nih.gov/pubmed/37324495
http://dx.doi.org/10.3389/fphar.2023.1208495

Ejemplares similares